US4603105A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Efficient screening methods for low probability variants
Assignee: Individual
•
Filing: 1982-05-27
•
Granted: 1986-07-29
•
Expires: 2002-05-27
Abstract
Abstract Rapid screening of a large number of organisms for variants producing particular products is accomplished using membrane plates having a predetermined molecular weight cutoff and which divide a container into two chambers. High density cellular lawns are employed in conjunction with labeled antibodies for the product of interest mixed in soft agar. The cells are subjected to viral lysis and after the plaques have reached maturity, the plates are immersed in buffer. Residual soluble labeled antibody diffuses from the agar, and immunoprecipitate of the product and the antibody may then be detected.
Inventors
- 👤 Donald A. Kaplan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 08:19
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/02; C12Q1/04; Y; Y10; Y10S; Y10S435/00; Y10S435/81
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
114 words
A method for screening organisms selected from the group consisting of viruses and cells, the viruses and cells being related in that the viruses are capable of lysing the cells, wherein said organisms may include a variant organism producing an antigenic marker, said method comprising combining in a gel: (1) said cells, (2) said viruses, and (3) a labeled receptor composition for said antigenic marker, under conditions where said labeled receptor composition and said marker combine to result in a non-diffusible aggregation; extracting labeled receptor which is not bound in said non-diffusible aggregation from said gel; and detecting said label in said gel at a location, said variant organism being present at that location.
Claim 2
Independent Claim
114 words
A method for screening organisms selected from the group consisting of viruses and cells, the viruses and cells being related in that the viruses are capable of lysing the cells, wherein said organisms may include a variant organism producing an antigenic marker, said method comprising combining in a gel: (1) said cells, (2) said viruses, and (3) a labeled receptor composition for said antigenic marker, under conditions where said labeled receptor composition and said marker combine to result in a non-diffusible aggregation; extracting labeled receptor which is not bound in said non-diffusible aggregation from said gel; and detecting said label in said gel at a location, said variant organism being present at that location.
Claim 3
Dependent Claim
12 words
A method according to claim 1 wherein said label is an enzyme.
Claim 4
Dependent Claim
16 words
A method according to claim 2, wherein said cells are bacteria and said viruses are phage.
Claim 5
Independent Claim
59 words
A method according to any of claims 1, 2 or 3, wherein said gel is comprised of a thick gel lower layer substantially free of labeled receptor and a thin gel upper layer containing said labeled receptor and separated by said lower layer by a membrane having a molecular weight cutoff below the molecular weight of said labeled receptor.
Claim 6
Independent Claim
78 words
An apparatus for use in screening organisms comprising an outer ring, internal to said outer ring, an inner ring extending into said outer ring only a portion of the height of said outer ring, said inner ring having an outer circumferential groove, an O-ring in said groove, and a membrane extending across the inner ring, with its outer portion locked between said inner and outer rings, said membrane having a molecular weight cutoff of less than about 100,000.
Claim 7
Independent Claim
78 words
An apparatus for use in screening organisms comprising an outer ring, internal to said outer ring, an inner ring extending into said outer ring only a portion of the height of said outer ring, said inner ring having an outer circumferential groove, an O-ring in said groove, and a membrane extending across the inner ring, with its outer portion locked between said inner and outer rings, said membrane having a molecular weight cutoff of less than about 100,000.
Claim 8
Dependent Claim
31 words
A kit comprising an apparatus according to claim 5, a multiplicity of membrane sheets, an enzyme composition capable of producing a chromogenic product and functionalized for covalent linking to an antibody.
Claim 9
Independent Claim
181 words
A method for screening organisms selected from the group consisting of cells and viruses capable of lysing the cells, wherein said organisms may include a variant organism producing an antigenic ligand, said method employing a screening apparatus including a membrane having a preselected molecular weight cutoff which defines two chambers, said method comprising: combining said cells and said viruses in a liquid gel; pouring said liquid gel into one chamber of the screening apparatus to form first gel layer; forming a second gel layer in the other chamber either before or after said first gel layer has been formed, said second gel layer being free from cells and viruses; exposing the first gel layer to diffusible labeled antibody specific for the marker, whereby non-diffusible labeled aggregations are formed in the presence of said antigenic ligand; removing said second gel layer; extracting the diffusible labeled antibody from the first gel layer by immersion in an aqueous solution; and detecting said label in the first gel layer at a location which is indicative of the presence of said variant organism at that location.
Claim 10
Independent Claim
181 words
A method for screening organisms selected from the group consisting of cells and viruses capable of lysing the cells, wherein said organisms may include a variant organism producing an antigenic ligand, said method employing a screening apparatus including a membrane having a preselected molecular weight cutoff which defines two chambers, said method comprising: combining said cells and said viruses in a liquid gel; pouring said liquid gel into one chamber of the screening apparatus to form first gel layer; forming a second gel layer in the other chamber either before or after said first gel layer has been formed, said second gel layer being free from cells and viruses; exposing the first gel layer to diffusible labeled antibody specific for the marker, whereby non-diffusible labeled aggregations are formed in the presence of said antigenic ligand; removing said second gel layer; extracting the diffusible labeled antibody from the first gel layer by immersion in an aqueous solution; and detecting said label in the first gel layer at a location which is indicative of the presence of said variant organism at that location.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-07-28 | 1990-01-27 | 1990-07-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-07-28 | 1994-01-27 | 1994-07-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-07-28 | 1998-01-27 | 1998-07-29 | $7700.00 | Window Closed / Lapsed |